b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2705343/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705343/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Pulmonary Medicine" /><meta name="citation_title" content="Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease" /><meta name="citation_authors" content="Matthias N Witt, Gerald S Braun, Stephan Ihrler, Holger Schmid" /><meta name="citation_date" content="2009" /><meta name="citation_volume" content="9" /><meta name="citation_doi" content="10.1186/1471-2466-9-22" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2705343/?report=abstract" /><meta name="citation_pmid" content="19450259" /><meta name="DC.Title" content="Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Matthias N Witt" /><meta name="DC.Contributor" content="Gerald S Braun" /><meta name="DC.Contributor" content="Stephan Ihrler" /><meta name="DC.Contributor" content="Holger Schmid" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1186/1471-2466-9-22" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease" /><meta property="og:type" content="article" /><meta property="og:description" content="Herpes simplex virus type-1 (HSV-1) has been described to cause respiratory tract infections in critically ill patients or in individuals that are immunocompromised. It is a continuing matter of debate under which circumstances HSV-1 is a relevant pathogen ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705343/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2705343/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2705343/pdf/12890_2008_Article_140.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B6B75E9A37A5100000000055C055C.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2705343</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Pulmonary Medicine</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Pulm Med</span>. 2009; 9: 22. </span></div><div><span class="fm-vol-iss-date">Published online 2009 May 18. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1471-2466-9-22" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1471-2466-9-22</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2705343</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19450259">19450259</a></div></div></div></div><h1 class="content-title">Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Witt%20MN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259" class="affpopup" co-rid="_co_idm139778184252080" co-class="co-affbox">Matthias N Witt</a>,<sup>1</sup> <a href="/pubmed/?term=Braun%20GS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259" class="affpopup" co-rid="_co_idm139778181317904" co-class="co-affbox">Gerald S Braun</a>,<sup>2</sup> <a href="/pubmed/?term=Ihrler%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259" class="affpopup" co-rid="_co_idm139778180618192" co-class="co-affbox">Stephan Ihrler</a>,<sup>3</sup> and  <a href="/pubmed/?term=Schmid%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259" class="affpopup" co-rid="_co_idm139778225862272" co-class="co-affbox">Holger Schmid</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>4</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139778184252080"><h3 class="no_margin">Matthias N Witt</h3><p><sup>1</sup>Department of Rheumatology, Medical Policlinic, University of Munich, Munich, Germany </p><div>Find articles by <a href="/pubmed/?term=Witt%20MN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259">Matthias N Witt</a></div></div><div id="_co_idm139778181317904"><h3 class="no_margin">Gerald S Braun</h3><p><sup>2</sup>Department of Nephrology and Clinical Immunology, RWTH University, Aachen, Germany </p><div>Find articles by <a href="/pubmed/?term=Braun%20GS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259">Gerald S Braun</a></div></div><div id="_co_idm139778180618192"><h3 class="no_margin">Stephan Ihrler</h3><p><sup>3</sup>Department of Pathology, University of Munich, Munich, Germany </p><div>Find articles by <a href="/pubmed/?term=Ihrler%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259">Stephan Ihrler</a></div></div><div id="_co_idm139778225862272"><h3 class="no_margin">Holger Schmid</h3><p><sup>4</sup>Department of Nephrology, Medical Policlinic, University of Munich, Munich, Germany </p><div>Find articles by <a href="/pubmed/?term=Schmid%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19450259">Holger Schmid</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139778185888320_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139778185888320_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139778185888320_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139778185888320_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Department of Rheumatology, Medical Policlinic, University of Munich, Munich, Germany </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Department of Nephrology and Clinical Immunology, RWTH University, Aachen, Germany </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>Department of Pathology, University of Munich, Munich, Germany </div><div class="fm-affl" lang="en" id="Aff4"><sup>4</sup>Department of Nephrology, Medical Policlinic, University of Munich, Munich, Germany </div><div><span class="fm-affl">Matthias N Witt, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcneum-inu.dem@ttiw.saihttam" class="oemail">ed.nehcneum-inu.dem@ttiw.saihttam</a></span>.</div><div><a href="#idm139778185888320aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139778185888320_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Nov 10; Accepted 2009 May 18.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139778185888320_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Witt et al; licensee BioMed Central Ltd. 2009</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2705343/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Herpes simplex virus type-1 (HSV-1) has been described to cause respiratory tract infections in critically ill patients or in individuals that are immunocompromised. It is a continuing matter of debate under which circumstances HSV-1 is a relevant pathogen for pneumonitis. While its role during critical illness has been investigated by prospective interventional studies, comparatively little systematic data is available on the role of HSV-1 for pneumonitis in outpatients with autoimmune disease under a maintenance regimen of immunosuppression.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">We retrospectively reviewed the charts of ~1400 patients with rheumatoid arthritis, vasculitis, and systemic lupus erythematosus (SLE) that were followed at the outpatient clinic of a German University hospital during the years 2000&#x02013;2007. Episodes of admission to a ward resulting in the diagnosis of pneumonia/pneumonitis were identified, and the type of pneumonia and clinical features retrospectively studied.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">63 patients with rheumatoid arthritis, vasculitis, or SLE were admitted to a ward and diagnosed to have pneumonia/pneumonitis. Using bronchoscopy a total of 6 cases of pulmonary infection associated with HSV-1 in the lower respiratory tract were identified. Among those, 2 cases suggested a causative role of HSV-1 as the sole agent causing pneumonitis that proved clinically responsive to antiviral treatment. In the remaining 4 cases HSV-1 appeared as a bystander of bacterial infection. Maintenance therapy with leflunomide, which inhibits HSV-1 assembly <em>in vitro</em>, was associated with a milder course of pneumonitis in one patient. Detection of HSV-1 was associated with stronger immunosuppressive regimens and vasculitic disease.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">The present study analyzed the frequency and hallmarks of cases of HSV-1 associated pneumonitis that occurred in a comparatively large cohort of patients with rheumatologic autoimmune diseases. In an area of controversy, this study provides further evidence that HSV-1 causes isolated pneumonitis in the immunocompromised. The study may provide an estimate on the frequency of relevant HSV-1 infection and bacterial agents in outpatients with autoimmune disease.</p></div><div id="__sec5" class="sec sec-last"><h3 id="__sec5title">Electronic supplementary material</h3><p id="__p5" class="p p-first-last">The online version of this article (doi:10.1186/1471-2466-9-22) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Systemic Lupus Erythematosus, Acyclovir, Leflunomide, Antiviral Treatment, Ground Glass Opacity</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p6" class="p p-first-last">After reactivation from latency in facial nerve ganglia, herpes simplex virus type-1 (HSV-1) may cause tracheobronchitis or pneumonitis featuring life-threatening respiratory-failure with bilateral changes on thoracic imaging [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091640">1</a>&#x02013;<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091637">4</a>]. HSV-1 pneumonitis is comparatively well investigated in critically ill patients under mechanical ventilation, where ~90% show an oropharyngeal reactivation of the virus within the first 10 days [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091642">5</a>]. In a number of retro- and prospective studies in this setting presence of cytology-proven HSV-1 pneumonitis was shown to have a poorer outcome, but antiviral treatment was not beneficial [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091650">6</a>&#x02013;<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091633">9</a>]. Immunosuppressed patients with malignancies, organ transplants, and cytotoxic treatments for various reasons are the other large, though extremely heterogeneous, group of patients that have been described to develop HSV-1 pneumonitis. Data on the disease in these subjects is more scarce and mainly consists of anecdotal accounts [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091629">10</a>&#x02013;<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091632">16</a>]. Only one retrospective study of bronchoalveolar lavage (BAL) microbiology/virology results from renal transplant patients is available and, very recently, a retrospective study on HSV-1 pneumonitis in patients with solid tumors was published representing the first systematic approaches in the field [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091628">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091646">18</a>]. In view of lack of data, it was the goal of the present study to investigate the potential significance of HSV-1 pneumonitis in patients under a maintenance regimen of ambulatory immunosuppression. We therefore retrospectively analyzed admissions for pneumonia/pneumonitis in a comparatively large cohort of outpatients with rheumatoid, vasculitic and connective tissue autoimmune disease over a period of 8 years.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><p id="__p7" class="p p-first">This retrospective study was approved by the local Ethics Committee. The local electronic database containing all patient diagnoses and discharge summaries of our rheumatologic outpatient clinic and the affiliated hospitals of the Department of internal medicine were searched for a combination of the terms of the rheumatologic/vasculitic/connective tissue disease and pneumonia or pneumonitis. Each episode of a positive hit was reviewed. Severity of current immunosuppressive treatment was scored 0&#x02013;4 as follows: 0 = no immunosuppressive medication; 1 = low-dose: (prednisone &#x02264; 10 mg/d) or (azulfidine/chloroquine); 2 = intermediate: (prednisone 20&#x02013;40 mg/d) or (prednisone 10 mg/d+methotrexate) or (prednisone 10 mg/d+leflunomide) or (cyclosporine) or (prednisone+mycophenolate mofetil) or (prednisone 20 mg/d+azathioprine); 3 = strong: (prednisone 40 mg/d+methotrexate) or (prednisone 20 mg/d+methotrexate+anakinra) or (prednisone 20 mg/d+methotrexate+leflunomide) or (prednisone 20 mg/d+etanercept) or (prednisone 40 mg/d+azathioprine) or (lower dose prednisone+azathioprine+leukopenia); 4 = maximal: (prednisone 60 mg/d+cyclophosphamide) or (prednisone 100 mg/d).</p><p id="__p8">At the time of in-hospital treatment the patients were diagnosed and treated by current standards of clinical practice and were not part of a prospective clinical trial regarding the treatment of pneumonia or pneumonitis.</p><p id="__p9">Fiberoptic bronchoscopy (FOB) was performed when deemed appropriate. Bronchoalveolar lavage (BAL) was performed with each bronchoscopic examination and material was subsequently centrifuged, fixated in 4% paraformaldehyde and stained using hematin-eosin. Standard microscopic examination was performed. BAL fluids were also subjected to viral polymerase chain reaction (PCR) when deemed appropriate that always consisted of testing for HSV-1 and CMV (cytomegaly virus). In selected positive cases immunohistochemistry of BAL for HSV-1 was performed using a rabbit polyclonal antibody against HSV-1 (DAKO Laboratories, Denmark). Bronchoscopic biopsies were performed when deemed appropriate and processed using standard protocols. Microbiologic and serologic diagnostics were performed using standard protocols.</p><p id="__p10" class="p p-last">Statistical analysis was performed using Prism 4 software (Graph Pad, La Jolla, CA).</p></div><div id="Sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec3title">Results</h2><p id="__p11" class="p p-first">As it is unclear to which extent an outpatient regimen of current standard immunosuppression for autoimmune disease may confer a risk for HSV-1 pneumonitis, we retrospectively reviewed the charts of ~1400 patients with rheumatoid arthritis (~1000), ANCA-associated vasculitis (~80), and systemic lupus erythematosus (SLE) (~320) that were followed during the years 2000&#x02013;2007 in the nephrology and rheumatology outpatient clinic at the Medical Policlinic, LMU University of Munich. During the study period 766 ward-admissions of patients with rheumatologic/vasculitic/connective tissue autoimmune disease occurred. Among those there were 63 (8%) episodes of admission from 63 outpatients of our clinic presenting with respiratory deterioration that were ultimately diagnosed to be due to pneumonia or pneumonitis (Table <a href="/pmc/articles/PMC2705343/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). As a rough estimate one can infer an incidence of community-acquired respiratory infection or pneumonitis requiring hospitalization in outpatients with autoimmune disease of [63 patients * 100/(1400 patients *8 years)], i.e., ~0.5% per year.\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p12">Classification and clinical course of the study population, i.e., 63 patients with rheumatic/vasculitic or connective tissue disease admitted to hospital and diagnosed to have pneumonia/pneumonitis</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139778183836448" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">Total admissions to hospital</th><th align="center" rowspan="1" colspan="1">Admissions for PNA (% of admissions)</th><th align="center" rowspan="1" colspan="1">FOB with BAL in PNA (% of PNA)</th><th align="center" rowspan="1" colspan="1">BAL-PCR for HSV-1 and CMV (% of FOB)</th><th align="center" rowspan="1" colspan="1">Positive HSV-1 BAL-PCR (% of PNA)</th><th align="center" rowspan="1" colspan="1">Requirement of intubation in PNA (% of PNA)</th><th align="center" rowspan="1" colspan="1">Mean and (median) age of patients with PNA in ys</th><th align="center" rowspan="1" colspan="1">Mean immuno-suppression severity score of patients with PNA*</th><th align="center" rowspan="1" colspan="1">Lethal outcome in PNA</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">\n<strong>Wegener\'s Granulomatosis</strong>\n</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">13 (18%)</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2 (cases 3, 5)</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">66 (68)</td><td align="center" rowspan="1" colspan="1">3.3</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Rheumatoid arthritis</strong>\n</td><td align="center" rowspan="1" colspan="1">515</td><td align="center" rowspan="1" colspan="1">34 (7%)</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2 (cases 1,4)</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">71 (74)</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Polyangiits</strong>\n</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">4 (18%)</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1 (case 2)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">63 (64)</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Systemic lupus erythematosus (SLE)</strong>\n</td><td align="center" rowspan="1" colspan="1">155</td><td align="center" rowspan="1" colspan="1">12 (8%)</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1 (case 6)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">53 (58)</td><td align="center" rowspan="1" colspan="1">1.6</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>total</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>766</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>63 (8%)</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>23 (37%)</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>14 (61%)</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>6 (10%)</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>8 (12%)</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>66 (66)</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>2.0</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>6 (10%)</strong>\n</td></tr></tbody></table></div><div id="largeobj_idm139778183836448" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2705343/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p13">Absolute numbers or percentages are given, (*) based on 56 of the 63 cases where information on immunosuppressive regimens was reliably available. In order to estimate the degree of immunosuppressive strength in the patient population, an arbitrary score ranging form 0&#x02013;4 was applied (see methods). Abbreviations: BAL = bronchoalveolar lavage, FOB = fiberoptic bronchoscopy, PNA = pneumonia/pneumonitis, ys = years.</p></div></div><p id="__p14">In 23 of these 63 patients bronchoscopy with lavage was performed for diagnostic purposes within the first four days of admission, which in 14 (61%) also comprised PCR analysis for HSV-1. Thereby a total of six patients (10% of admissions for pneumonia) with positive HSV-1 DNA detection in alveolar fluids was identified. In order to estimate the degree of immunosuppressive strength in the patient population, an arbitrary score ranging form 0&#x02013;4 was applied (see methods).</p><p id="__p15">Relevant clinical, imaging and laboratory data on the six patients with a positive HSV-1 DNA detection on BAL are summarized in Table <a href="/pmc/articles/PMC2705343/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2</span></span><span>2</span></a>.\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p16">Synopsis of patient data on all cases with a positive HSV-1 result on PCR of bronchoalveolar lavage</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139778184088336" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Clinical data</th><th align="center" rowspan="1" colspan="1">Case 1</th><th align="center" rowspan="1" colspan="1">Case 2</th><th align="center" rowspan="1" colspan="1">Case 3</th><th align="center" rowspan="1" colspan="1">Case 4</th><th align="center" rowspan="1" colspan="1">Case 5</th><th align="center" rowspan="1" colspan="1">Case 6</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age at presentation (yrs), gender</td><td align="center" rowspan="1" colspan="1">74, f</td><td align="center" rowspan="1" colspan="1">74, m</td><td align="center" rowspan="1" colspan="1">60, m</td><td align="center" rowspan="1" colspan="1">67, m</td><td align="center" rowspan="1" colspan="1">72, m</td><td align="center" rowspan="1" colspan="1">65, f</td></tr><tr><td align="left" rowspan="1" colspan="1">Rheumatological diagnosis (duration in years)</td><td align="center" rowspan="1" colspan="1"><p id="__p17">Rheumatoid arthritis, seronegative</p><p id="__p18">8</p></td><td align="center" rowspan="1" colspan="1"><p id="__p19">pulmonary microscopic Polyangiitis</p><p id="__p20">3</p></td><td align="center" rowspan="1" colspan="1"><p id="__p21">Wegener\'s Granulomatosis</p><p id="__p22">2</p></td><td align="center" rowspan="1" colspan="1"><p id="__p23">Rheumatoid arthritis, seropositive</p><p id="__p24">10</p></td><td align="center" rowspan="1" colspan="1"><p id="__p25">Wegener\'s Granulomatosis</p><p id="__p26">8</p></td><td align="center" rowspan="1" colspan="1"><p id="__p27">Systemic lupus erythematosus</p><p id="__p28">4</p></td></tr><tr><td align="left" rowspan="1" colspan="1">Co-Morbidities</td><td align="center" rowspan="1" colspan="1">allergic asthma</td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">renal insufficiency</td><td align="center" rowspan="1" colspan="1">diabetes, septic arthritis</td><td align="center" rowspan="1" colspan="1">HHT, renal insufficiency</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Immunosuppression (severity score)</td><td align="center" rowspan="1" colspan="1">Pred 20 mg/d + MTX 15 mg/w + Lefl 20 mg/d (3)</td><td align="center" rowspan="1" colspan="1"><p id="__p29">Pred 50 mg/d + Cyclo 150 mg/d p.o.</p><p id="__p30">(4)</p></td><td align="center" rowspan="1" colspan="1"><p id="__p31">Pred 20 mg/d +Cyclo 150 mg/d</p><p id="__p32">(4)</p></td><td align="center" rowspan="1" colspan="1">Pred 20 mg/d + MTX 7.5 mg/w + Anakinra 100 mg/d (3)</td><td align="center" rowspan="1" colspan="1"><p id="__p33">Pred 40 mg/d + Cyclo 500 mg/m i.v.</p><p id="__p34">(4)</p></td><td align="center" rowspan="1" colspan="1"><p id="__p35">Pred 20 mg/d + Aza 150 mg/d, pancytopenia</p><p id="__p36">(3)</p></td></tr><tr><td align="left" rowspan="1" colspan="1">clinical presentation in the outpatient setting prior to admission</td><td align="center" rowspan="1" colspan="1">21 days of cough, fever</td><td align="center" rowspan="1" colspan="1">3 days of bloody cough, dysphagia</td><td align="center" rowspan="1" colspan="1">3 days of dyspnea, syncope</td><td align="center" rowspan="1" colspan="1">7 days of dyspnea, cough</td><td align="center" rowspan="1" colspan="1">5 days of dyspnea, cough, weakness</td><td align="center" rowspan="1" colspan="1">1 day of dyspnea, non-productive cough</td></tr><tr><td align="left" rowspan="1" colspan="1">Notable findings</td><td align="center" rowspan="1" colspan="1">HSV-1 positive oral lesion</td><td align="center" rowspan="1" colspan="1">none</td><td align="center" rowspan="1" colspan="1">HSV-1 positive oral lesion</td><td align="center" rowspan="1" colspan="1">none</td><td align="center" rowspan="1" colspan="1">HSV-1 positive nasal lesion</td><td align="center" rowspan="1" colspan="1">none</td></tr><tr><td align="left" rowspan="1" colspan="1">Ventilatory support required</td><td align="center" rowspan="1" colspan="1">CPAP</td><td align="center" rowspan="1" colspan="1">no</td><td align="center" rowspan="1" colspan="1">intubation</td><td align="center" rowspan="1" colspan="1">intubation</td><td align="center" rowspan="1" colspan="1">no</td><td align="center" rowspan="1" colspan="1">no</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Radiological findings</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Chest-XR</td><td align="center" rowspan="1" colspan="1">diffuse bilateral ground-glass opacities</td><td align="center" rowspan="1" colspan="1">interstitial pattern</td><td align="center" rowspan="1" colspan="1">interstitial pattern</td><td align="center" rowspan="1" colspan="1">bilateral bronchopneumonic infiltrates with pleural effusions</td><td align="center" rowspan="1" colspan="1">bilateral bronchopneumonic infiltrates</td><td align="center" rowspan="1" colspan="1">unilateral infiltrate</td></tr><tr><td align="left" rowspan="1" colspan="1">High-resolution CT-scan</td><td align="center" rowspan="1" colspan="1">diffuse bilateral ground-glass opacities</td><td align="center" rowspan="1" colspan="1">right-sided diffuse pleural effusions</td><td align="center" rowspan="1" colspan="1">diffuse bilateral ground-glass opacities (no granulomas)</td><td align="center" rowspan="1" colspan="1">extensive bilateral bronchopneumonic infiltrates with pleural effusions, atelectasis, hilar lymphadenopathy</td><td align="center" rowspan="1" colspan="1">diffuse bilateral granulomas</td><td align="center" rowspan="1" colspan="1">unilateral bronchopneumonic infiltrate</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Bronchoscopy/pathology</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">performed on hospital day</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Macroscopic mucosal aspect</td><td align="center" rowspan="1" colspan="1">Vulnerable, inflammamation</td><td align="center" rowspan="1" colspan="1">normal</td><td align="center" rowspan="1" colspan="1">inflammation</td><td align="center" rowspan="1" colspan="1">acute bronchitis</td><td align="center" rowspan="1" colspan="1">vulnerable, acute bronchitis</td><td align="center" rowspan="1" colspan="1">vulnerable</td></tr><tr><td align="left" rowspan="1" colspan="1">BAL cytology: inclusion bodies</td><td align="center" rowspan="1" colspan="1">Positive</td><td align="center" rowspan="1" colspan="1">positive</td><td align="center" rowspan="1" colspan="1">positive</td><td align="center" rowspan="1" colspan="1">n.a.</td><td align="center" rowspan="1" colspan="1">n.a.</td><td align="center" rowspan="1" colspan="1">n.a.</td></tr><tr><td align="left" rowspan="1" colspan="1">Lung biopsy</td><td align="center" rowspan="1" colspan="1">Non-specific (chronic) bronchitis</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">non-specific fibroelastosis</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td></tr><tr><td align="left" rowspan="1" colspan="1">HSV-1 immunohistology of BAL cytology or of lung biopsy</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">positive</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Relevant identified infectious agents of pneumonia/pneumonitis (from BAL)</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>HSV-1 as sole agent</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>HSV-1 as sole agent</strong>\n</td><td align="center" rowspan="1" colspan="1">Aspergillus, K. pneumoniae, HSV-1</td><td align="center" rowspan="1" colspan="1">MRSA, P. aeruginosa, K. pneumoniae, HSV-1</td><td align="center" rowspan="1" colspan="1">S. aureus, P. aeruginosa, Influenza A, HSV-1</td><td align="center" rowspan="1" colspan="1">S. aureus (coag neg), P. aeruginosa, Enterococci, HSV-1, M. kansasii</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Treatment</strong>\n</td><td align="center" rowspan="1" colspan="1"><p id="__p37">- day 1: ceftriax+ery (for 7 days; overlap with acyclo 5 days)</p><p id="__p38">- day 2: acyclo</p></td><td align="center" rowspan="1" colspan="1"><p id="__p39">- day 1: moxi (for 2 days)</p><p id="__p40">- day 2: swap to acyclo monotherapy</p></td><td align="center" rowspan="1" colspan="1"><p id="__p41">- day 1: mero + ery + fluc</p><p id="__p42">- day 2: add acyclo + amphoB for fluc</p><p id="__p43">- later: add cipro+ tobra + vanco for mero</p></td><td align="center" rowspan="1" colspan="1"><p id="__p44">sequential:</p><p id="__p45">- ceftr+moxi</p><p id="__p46">- genta+tazo+fluc</p><p id="__p47">- mero</p><p id="__p48">- vanc+linez</p><p id="__p49">from day 2: acyclo</p></td><td align="center" rowspan="1" colspan="1"><p id="__p50">sequential:</p><p id="__p51">- metro+clari +ceftriax</p><p id="__p52">- day 3 ceftaz for ceftriax</p></td><td align="center" rowspan="1" colspan="1"><p id="__p53">sequential:</p><p id="__p54">- clari+cipro+ceftaz</p><p id="__p55">- fluc (for 14 days)</p><p id="__p56">from day 14: INH+ rifampicin+ethambutol</p></td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Outcome</strong>\n</td><td align="center" rowspan="1" colspan="1">recovery after 7 days</td><td align="center" rowspan="1" colspan="1">recovery after 11 days</td><td align="center" rowspan="1" colspan="1">lethal after 28 days (ARDS)</td><td align="center" rowspan="1" colspan="1">lethal after 33 days (ARDS)</td><td align="center" rowspan="1" colspan="1">Initial recovery after 28 days, but lethal after 110 days (ARDS) with persistant high HSV-1 viral load on BAL</td><td align="center" rowspan="1" colspan="1">recovery after 38 days</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Our Diagnosis/comment</strong>\n</td><td align="center" rowspan="1" colspan="1">most likely isolated HSV-1 pneumonitis</td><td align="center" rowspan="1" colspan="1">most likely isolated HSV-1 pneumonitis</td><td align="center" rowspan="1" colspan="1">Bacterial, fungal and HSV-1 pneumonia/pneumonits</td><td align="center" rowspan="1" colspan="1">Bacterial bronchopneumonia with HSV-1 reactivation</td><td align="center" rowspan="1" colspan="1">Bacterial pneumonia with untreated HSV-1 reactivation. A second BAL PCR showed an increasing viral load</td><td align="center" rowspan="1" colspan="1">Mycobacteriosis due to M. kansasii (responsive to treatment). HSV-1 reactivation without radiographic signs of pneumonitis that was not treated antivirally.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Complete microbiological work-up</strong>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Blood cultures</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Mycobacteria culture/PCR BAL</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong> (M. kansasii)</td></tr><tr><td align="left" rowspan="1" colspan="1">Aspergillus</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong> (serum Ag &#x00026; culture)</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">negative (serum AG)</td></tr><tr><td align="left" rowspan="1" colspan="1">P. jirovecii BAL</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td></tr><tr><td align="left" rowspan="1" colspan="1">MRSA culture Sputum</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong>\n</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td></tr><tr><td align="left" rowspan="1" colspan="1">P. aeruginosa culture BAL</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">K. pneumoniae culture BAL</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong>\n</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong>\n</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td></tr><tr><td align="left" rowspan="1" colspan="1">M. pneumoniae</td><td align="center" rowspan="1" colspan="1">negative (PCR BAL)</td><td align="center" rowspan="1" colspan="1">negative (serology)</td><td align="center" rowspan="1" colspan="1">negative (serology)</td><td align="center" rowspan="1" colspan="1">negative (PCR BAL)</td><td align="center" rowspan="1" colspan="1">negative (PCR BAL)</td><td align="center" rowspan="1" colspan="1">n.p.</td></tr><tr><td align="left" rowspan="1" colspan="1">C. trachomatis/pneumoniae</td><td align="center" rowspan="1" colspan="1">negative (serology)</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">negative (PCR BAL)</td><td align="center" rowspan="1" colspan="1">negative (PCR BAL)</td><td align="center" rowspan="1" colspan="1">negative (PCR BAL)</td><td align="center" rowspan="1" colspan="1">negative (PCR BAL)</td></tr><tr><td align="left" rowspan="1" colspan="1">Legionella-Ag (Urine)</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">n.p.</td></tr><tr><td align="left" rowspan="1" colspan="1">Complete virological work-up</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">HSV-1 PCR BAL, Geq/ml</td><td align="center" rowspan="1" colspan="1">9.750.000</td><td align="center" rowspan="1" colspan="1">284.000</td><td align="center" rowspan="1" colspan="1">700.000</td><td align="center" rowspan="1" colspan="1">850.000</td><td align="center" rowspan="1" colspan="1">10.250.000</td><td align="center" rowspan="1" colspan="1">310.000</td></tr><tr><td align="left" rowspan="1" colspan="1">CMV-PCR BAL</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Influenza A PCR BAL* (season of presentation)</td><td align="center" rowspan="1" colspan="1">n.p. (May)</td><td align="center" rowspan="1" colspan="1">n.p. (April)</td><td align="center" rowspan="1" colspan="1">negative (January)</td><td align="center" rowspan="1" colspan="1">n.p. (September)</td><td align="center" rowspan="1" colspan="1">\n<strong>positive</strong> (February)</td><td align="center" rowspan="1" colspan="1">n.p. (June)</td></tr><tr><td align="left" rowspan="1" colspan="1">Adenovirus PCR BAL**</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td></tr><tr><td align="left" rowspan="1" colspan="1">HIV-1/2-Ag ELISA</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">n.p.</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">n.p.</td></tr></tbody></table></div><div id="largeobj_idm139778184088336" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2705343/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p57">Abbreviations used are: acyclo = acyclovir, Ag = antigen, amphoB = amphotericin B, ARDS = adult respiratory distress syndrome, Aza = azathioprine, BAL = bronchoalveolar lavage, ceftaz = ceftazidime, ceftriax = ceftriaxone, cipro = ciprofloxacin, clari = clarithromycin, CPAP = continuous positive airway pressure, CT = computed tomography, coag neg = coagulase negative, cyclo = cyclophosphamide, d = day, ery = erythromycin, fluc = fluconazole, genta = gentamycin, Geq/ml = genome equivalents/ml; HHT = hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome), INH = isoniazid, Lefl = leflunomide, linez = linezolid, mero = meropenem, metro = metronidazole, moxi = moxifloxacin, MTX = methotrexate, Pred = prednisone, tazo = piperacillin/tazobactam, tobra = tobramycin, vanco = vancomycin, w = week. *testing was seasonal during winter only. **testing was at the discretion of the physician performing bronchoscopy.</p></div></div><p id="__p58">Two cases (Case 1 and 2) in which no other viral, bacterial or fungal agent than HSV-1 on BAL PCR was found and in which imaging studies were suggestive for HSV-1 pneumonitis were successfully treated with acyclovir leading to rapid clinical improvement. In both cases, the initial chest radiograph and thoracic CT showed diffuse infiltrations or ground glass opacities. Representative images are shown in Figure <a href="/pmc/articles/PMC2705343/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1A, B</span></a>. HSV-1 infection may feature a macroscopically vulnerable aspect of the bronchial mucosa as a non-specific sign (Figure <a href="/pmc/articles/PMC2705343/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1C).</span></span><span>1C</span></a>). In order to increase diagnostic certainty in Case 2, immunohistochemical staining of bronchioalveolar cells for HSV-1 was performed, which proved positive (Figure <a href="/pmc/articles/PMC2705343/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2).</span></span><span>2</span></a>). In both cases inclusion bodies of epithelial cells from BAL were present. Our diagnosis in Case 1 and 2 was isolated HSV-1 pneumonitis, which was supported by the response to acyclovir in the absence of prolonged antibacterial treatment.\n\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2705343/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139778227067344" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12890_2008_Article_140_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12890_2008_Article_140_Fig1_HTML.jpg" src="/pmc/articles/PMC2705343/bin/12890_2008_Article_140_Fig1_HTML.jpg" /></div><div id="largeobj_idm139778227067344" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2705343/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2705343/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p59">\n<strong>Imaging study from Case 1</strong>. A: Conventional chest radiograph with diffuse interstital pattern. B: High-resolution-CT (HRCT) featuring small pleural effusions and partial atelectasis of the right lower lobe in addition to distinctive ground-glass opacities. C: Fiberoptic bronchoscopy image showing a vulnerable tracheobronchial mucosa with multiple spontaneous bleeding stigmata, consistent with generalized tracheobronchial inflammation.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2705343/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139778227088672" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12890_2008_Article_140_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12890_2008_Article_140_Fig2_HTML.jpg" src="/pmc/articles/PMC2705343/bin/12890_2008_Article_140_Fig2_HTML.jpg" /></div><div id="largeobj_idm139778227088672" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2705343/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2705343/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p60">\n<strong>Immunohistochemical staining for HSV-1 in a fixated cyotspun obtained from BAL from Case 2 identifying a positive cell (dark brown colour)</strong>. Bottom and left: alveolar macrophages and lymphocytes with degenerative changes.</p></div></div></div><p id="__p61">Case 3 and 4 displayed an initial co-infection with fungal or bacterial agents and HSV-1 and required prolonged mechanical ventilation. Imaging studies were compatible with viral pneumonitis, but in Case 4 infiltrates suggesting bronchopneumonia were also clearly present. The mucosa was macroscopically inflamed in both cases. While Case 3 had inclusion bodies on cytology, such studies were not pursued in Case 4 due to obvious bronchopneumonia. Both patients had a fatal outcome after a prolonged in-hospital stay despite adequate antiinfective treatment that included timely administration of acyclovir.</p><p id="__p62">Cases 5 and 6 are different from the former four cases therein that no bilateral groundglass opacities were present on thoracic CT and no antiviral treatment was initiated. In Case 5, a high HSV-1 viral load from BAL fluids was ignored given the detection of Influenza A virus with S. aureus and Ps. aeruginosa. The patient improved on antibacterial treatment alone and was discharged. He was readmitted one month later with <em>de-novo</em> respiratory deterioration that resulted in the need for intubation after the administration of a series of antimicrobial courses that always excluded acyclovir. CT and a second BAL now showed ground glass opacities/ARDS and an even higher HSV-1 viral load. The patient died from ARDS before antiviral treatment could be initiated. Case 6 featured an unilateral bronchopneumonic infiltrate and was treated with standard antibacterial regimens until <em>Mycobacterium kansasii</em> grew from the initial BAL. Treatment was changed accordingly and the patient recovered without the administration of antivirals.</p><p id="__p63">In an area of controversy, the first two cases provide further evidence that in selected patients, if ascertained to be the sole agent, HSV-1 is a relevant pathogen of pneumonitis that is amenable to treatment. Cases 3&#x02013;6 reflect the great difficulty of dissecting the role of HSV-1 in infections with multiple pathogens [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091644">19</a>] and illustrate that HSV-1 pneumonitis is a diagnosis of exclusion requiring a complete microbiological workup. It remains speculative if timely suppression of HSV-1 viral loads by antiviral treatment in Case 5 would have altered the patient\'s course.</p><p id="__p64">In the present study of 63 patients with autoimmune disease and pneumonia/pneumontis, no offending agent could be found in 60% of cases. In the remaining 40% a broad spectrum of bacteria, fungi and viruses was identified (Figure <a href="/pmc/articles/PMC2705343/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3A).</span></span><span>3A</span></a>). Of note, one case of pneumonitis was due to methotrexate. Two cases (3.2%) were most likely due to HSV-1, while HSV-1 was a bystander of other agents in the remaining four cases.\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC2705343/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139778180519584" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12890_2008_Article_140_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12890_2008_Article_140_Fig3_HTML.jpg" src="/pmc/articles/PMC2705343/bin/12890_2008_Article_140_Fig3_HTML.jpg" /></div><div id="largeobj_idm139778180519584" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2705343/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC2705343/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p65">\n<strong>A: Detected primary responsible (leading) infectious agents in 63 patients with ambulatory-acquired pneumonia/pneumonitis and autoimmune disease</strong>. RSV = respiratoy syncytial virus. B: Immunosuppression scores were significantly more severe in the 6 patients with HSV-1 detection in BAL than in those subjects without clinical or laboratory evidence for HSV-1 (as assessed for 56/63 patients with reliable information on immunosuppressive regimens available; ** p &#x0003c; 0.01, Mann-Whitney two-sided test).</p></div></div></div><p id="__p66" class="p p-last">When comparing the six HSV-1-positive cases to those where HSV-1 was neither detected nor suspected with respect to the severity of immunosuppression, a significantly higher degree of immunosuppression in the HSV-1-positive group was noted (p &#x0003c; 0.01, two-sided Mann-Whitney analysis) (Figure <a href="/pmc/articles/PMC2705343/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3B).</span></span><span>3B</span></a>). This analysis was performed including 56 of the 63 patients where reliable information on maintenance immunosuppression was available. In order to exclude selection bias, the comparison was also performed using the subgroup of 8 patients that were proven to be HSV-1 negative by BAL. Albeit not reaching the same level of significance, a similar trend was observed with a similar median immunosuppression severity score of 2.0 in the HSV-1 negative group (data not shown). Though great caution must be applied in interpreting small numbers, it is intriguing that patients with Wegener\'s Granulomatosis and vasculitis, who had the strongest immunosuppression (score 3.3&#x02013;3.5) also had a HSV-1 positive BAL more often (15&#x02013;25% of pneumonia/pneumonitis) than Rheumatoid arthritis and SLE patients (6&#x02013;8% of pneumonia/pneumonitis) who were also on a milder immunosuppressive regimen (score 1.5&#x02013;1.6) (Table <a href="/pmc/articles/PMC2705343/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1</span></span><span>1</span></a>).</p></div><div id="Sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec4title">Discussion</h2><p id="__p67" class="p p-first">Patients with systemic autoimmune disease have an alteration of immune responses that is due to both the action of immunosuppressive treatment and to the underlying condition itself [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091630">20</a>, <a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091654">21</a>]. They are at increased risk for developing opportunistic infections among which respiratory tract involvement is associated with potentially adverse outcomes. Clinical workup of respiratory deterioration in this setting is complicated by the fact that not only bacterial, fungal or viral infectious agents but also a pulmonary flare of the systemic disease or drug-related pulmonary toxicity must be taken into the differential diagnosis. Indicators that raise suspicion for HSV-1 pneumonitis in immunocompromised patients are severe respiratory insufficiency combined with pathologic findings on imaging studies. Thoracic radiographs show segmental bilateral opacities (~95%) and pleural effusions (~50%) while CT may show ground-glass opacities (~100%), focal consolidations (~75%), and pleural effusions (~88%) [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091635">22</a>, <a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091651">23</a>]. Especially ground-glass opacities are a useful diagnostic hint in the immunocompromised, suggesting either an opportunistic infection due to Pneumocystis jirovecii, CMV, HSV-1, or other viruses [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091655">24</a>]. Other non-infectious differential diagnoses of ground glass opacities have been reviewed by [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091636">24</a>].</p><p id="__p68">HSV-1 pneumonitis is a diagnosis of exclusion relying on clinical plausibility, positive viral testing, and imaging studies. The definition of clinically relevant positive viral testing is a matter of controversy. A recent study in patients under prolonged mechanical ventilation by Luyt <em>et al</em>. required the combination of (i) clinical deterioration, (ii) HSV-1 detection in the lower respiratory tract by either PCR or culture, and (iii) cytological or histological evidence of inclusion bodies from either BAL fluids or biopsies to specifically define HSV-1 pneumonitis [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091638">9</a>]. While viral cultures are difficult to handle, PCR of BAL fluids has become the most popular diagnostic tool since it is easily performed and sports a high sensitivity. Specificity however, may be lacking due to potential contamination with fluids from oropharyngeal reactivation, which may even occur in plain bacterial pneumonia [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091657">5</a>, <a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091656">9</a>, <a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091645">19</a>, <a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091653">25</a>]. Indeed, in Luyt\'s study, only 43% of those with a positive PCR result also had cytological/histological evidence of infection. Conversely, these cytological/histological criteria lack sensitivity as illustrated by the fact that even open lung biopsies may be negative in the case of autopsy-proven HSV-1 pneumonitis [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091652">4</a>]. From a theoretical point of view, HSV-1 viraemia could be an additional specific diagnostic tool, which is, again, associated with a marked reduction in sensitivity [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091643">9</a>].</p><p id="__p69">A careful microbiological and remaining virological workup is necessary to define by exclusion isolated HSV-1 pneumonitis. Unfortunately, results of bacterial sampling are often falsely negative, be it due to inadequately low amounts material, assay insensitivity or prior antibiotic use, to name just a few. This is also illustrated by the 60% of cases of pneumonia in our study in which no offending agent was detected despite clinical evidence of infection. Hence, the possibility of falsely negative bacterial testing also applies as a <em>caveat</em> to our Cases 1 and 2. Our centre performed viral testing of BAL fluids for influenza routinely during winter. Concerning other viruses such as adenovirus and coronavirus each centre should define a standard in order to avoid omission or over-testing.</p><p id="__p70">Viral load of BAL fluids detected by PCR correlates positively with the presence of cytology/histology-proven HSV-1 pneumonitis and negatively with outcome [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091639">6</a>, <a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091649">9</a>, <a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091647">16</a>], but is not necessarily helpful in establishing the diagnosis due to potentially great variations in sampling conditions. However, it is intriguing that Case 1 in our series who was on treatment with leflunomide showed a viral load (9.750.000 Geq/ml) that was 3 and 13-fold greater than the detected average (3.700.000) and median (775.000) of all cases, respectively, while the clinical course was prolonged (21 days prior to admission to hospital) and comparatively mild. Leflunomide exhibits antiviral effects against HSV-1 by inhibiting the assembly of viral capsids but not DNA-replication at dosages used in rheumatic patients [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091641">26</a>]. It is tempting to speculate, that leflunomide might have led to the shedding of ill-assembled virions in Case 1.</p><p id="__p71" class="p p-last">As outlined in the introduction, studies on HSV-1 pneumonitis in patients with various immunosuppressive conditions are just beginning to emerge [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091631">27</a>]. The present study retrospectively analyzed admissions for pneumonia/pneumonitis in a comparatively large cohort of outpatients with autoimmune disease under a maintenance regimen of immunosuppression. Although the considerable limitations of a retrospective design must be borne in mind, the data provide some perspective on the frequency of HSV-1 and other bacterial, fungal and viral agents leading to pulmonary infection in this patient group.</p></div><div id="Sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec5title">Conclusion</h2><p id="__p72" class="p p-first-last">Respiratory deterioration and pneumonia leading to hospital admission was a common event in outpatients with autoimmune diseases treated with current standard immunosuppressive regimens. Acute life-threatening respiratory failure associated with the detection of HSV-1 in the lower respiratory tract was a rare, but significant finding. Based on our findings, diagnostic virological workup in this particular patient cohort should include HSV-1 before starting, but without delaying treatment. In an area of controversy [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091634">19</a>, <a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844091648">28</a>], we provide further evidence that immunocompromised patients may develop a condition that is most accurately described as HSV-1 pneumonitis and that appears amenable to treatment.</p></div><div id="idm139778181783088" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139778181783088title">Acknowledgements</h2><div class="sec"><p id="__p81">Dr. Benedikt Huttner, Geneva, is greatfully acknowledged for useful discussions.</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec6" class="sec sec-first"><h3 id="Sec6title">Authors&#x02019; original submitted files for images</h3><p id="__p73" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC2705343/bin/12890_2008_140_MOESM1_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(316K, jpeg)</sup></span>\n<span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC2705343/bin/12890_2008_140_MOESM2_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(146K, jpeg)</sup></span>\n<span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC2705343/bin/12890_2008_140_MOESM3_ESM.jpeg" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(306K, jpeg)</sup></span>\n</p></div></div><div id="idm139778181786576" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139778181786576title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139778181786448"><p id="__p77" class="p p-first"><strong>Competing interests</strong></p><p id="__p78" class="p p-last">The authors have no affiliation or significant financial involvement in any organizations or entity with a direct financial interest in the subject matter or materials discussed in the manuscript. This includes employment, honoraria, consultancies, or relevant stock ownership.</p></p><p class="fn sec" id="idm139778181784912"><p id="__p79" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p80" class="p p-last">MNW carried out the retrospective chart review, analyzed the data and helped to draft the manuscript. GSB drafted the manuscript including figures and tables and participated substantially in the coordination of the study and the analysis of data. SI processed the cytological samples from BAL and evaluated the lung biopsies. HS had the idea for the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript. MNW and GSB contributed equally and are both considered first authors.</p></p></div></div><div id="idm139778185888320aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139778185888320aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Matthias N Witt, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcneum-inu.dem@ttiw.saihttam" class="oemail">ed.nehcneum-inu.dem@ttiw.saihttam</a></span>.</p><p><span class="fm-affl">Gerald S Braun, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcaaku@nuarbg" class="oemail">ed.nehcaaku@nuarbg</a></span>.</p><p><span class="fm-affl">Stephan Ihrler, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcneum-inu.dem@relrhi.nahpets" class="oemail">ed.nehcneum-inu.dem@relrhi.nahpets</a></span>.</p><p><span class="fm-affl">Holger Schmid, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcneum-inu.zrl@dimhcs.regloh" class="oemail">ed.nehcneum-inu.zrl@dimhcs.regloh</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Whitley RJ, Roizman B. Herpes simplex virus infections. <span><span class="ref-journal">Lancet. </span>2001;<span class="ref-vol">357</span>(9267):1513\xe2\x80\x931518. doi: 10.1016/S0140-6736(00)04638-9.</span> [<a href="/pubmed/11377626" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(00)04638-9" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Herpes+simplex+virus+infections&amp;author=RJ+Whitley&amp;author=B+Roizman&amp;volume=357&amp;issue=9267&amp;publication_year=2001&amp;pages=1513-1518&amp;pmid=11377626&amp;doi=10.1016/S0140-6736(00)04638-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Tunback P, Bergstrom T, Claesson BA, Carlsson RM, Lowhagen GB. Early acquisition of herpes simplex virus type 1 antibodies in children &#x02013; a longitudinal serological study. <span><span class="ref-journal">J Clin Virol. </span>2007;<span class="ref-vol">40</span>(1):26\xe2\x80\x9330. doi: 10.1016/j.jcv.2007.06.002.</span> [<a href="/pubmed/17644470" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jcv.2007.06.002" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&amp;title=Early+acquisition+of+herpes+simplex+virus+type+1+antibodies+in+children+&#x02013;+a+longitudinal+serological+study&amp;author=P+Tunback&amp;author=T+Bergstrom&amp;author=BA+Claesson&amp;author=RM+Carlsson&amp;author=GB+Lowhagen&amp;volume=40&amp;issue=1&amp;publication_year=2007&amp;pages=26-30&amp;pmid=17644470&amp;doi=10.1016/j.jcv.2007.06.002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Schuller D, Spessert C, Fraser VJ, Goodenberger DM. Herpes simplex virus from respiratory tract secretions: epidemiology, clinical characteristics, and outcome in immunocompromised and nonimmunocompromised hosts. <span><span class="ref-journal">Am J Med. </span>1993;<span class="ref-vol">94</span>(1):29\xe2\x80\x9333. doi: 10.1016/0002-9343(93)90116-7.</span> [<a href="/pubmed/8380535" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0002-9343(93)90116-7" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Med&amp;title=Herpes+simplex+virus+from+respiratory+tract+secretions:+epidemiology,+clinical+characteristics,+and+outcome+in+immunocompromised+and+nonimmunocompromised+hosts&amp;author=D+Schuller&amp;author=C+Spessert&amp;author=VJ+Fraser&amp;author=DM+Goodenberger&amp;volume=94&amp;issue=1&amp;publication_year=1993&amp;pages=29-33&amp;pmid=8380535&amp;doi=10.1016/0002-9343(93)90116-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Ramsey PG, Fife KH, Hackman RC, Meyers JD, Corey L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. <span><span class="ref-journal">Ann Intern Med. </span>1982;<span class="ref-vol">97</span>(6):813\xe2\x80\x93820. doi: 10.7326/0003-4819-97-6-813.</span> [<a href="/pubmed/6293356" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.7326%2F0003-4819-97-6-813" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Herpes+simplex+virus+pneumonia:+clinical,+virologic,+and+pathologic+features+in+20+patients&amp;author=PG+Ramsey&amp;author=KH+Fife&amp;author=RC+Hackman&amp;author=JD+Meyers&amp;author=L+Corey&amp;volume=97&amp;issue=6&amp;publication_year=1982&amp;pages=813-820&amp;pmid=6293356&amp;doi=10.7326/0003-4819-97-6-813&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Bruynseels P, Jorens PG, Demey HE, Goossens H, Pattyn SR, Elseviers MM, Weyler J, Bossaert LL, Mentens Y, Ieven M. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">362</span>(9395):1536\xe2\x80\x931541. doi: 10.1016/S0140-6736(03)14740-X.</span> [<a href="/pubmed/14615108" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(03)14740-X" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Herpes+simplex+virus+in+the+respiratory+tract+of+critical+care+patients:+a+prospective+study&amp;author=P+Bruynseels&amp;author=PG+Jorens&amp;author=HE+Demey&amp;author=H+Goossens&amp;author=SR+Pattyn&amp;volume=362&amp;issue=9395&amp;publication_year=2003&amp;pages=1536-1541&amp;pmid=14615108&amp;doi=10.1016/S0140-6736(03)14740-X&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Linssen CF, Jacobs JA, Stelma FF, van Mook WN, Terporten P, Vink C, Drent M, Bruggeman CA, Smismans A. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. <span><span class="ref-journal">Intensive Care Med. </span>2008;<span class="ref-vol">34</span>(12):2202\xe2\x80\x939. doi: 10.1007/s00134-008-1231-4.</span> [<a href="/pubmed/18679655" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00134-008-1231-4" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med&amp;title=Herpes+simplex+virus+load+in+bronchoalveolar+lavage+fluid+is+related+to+poor+outcome+in+critically+ill+patients&amp;author=CF+Linssen&amp;author=JA+Jacobs&amp;author=FF+Stelma&amp;author=WN+van+Mook&amp;author=P+Terporten&amp;volume=34&amp;issue=12&amp;publication_year=2008&amp;pages=2202-9&amp;pmid=18679655&amp;doi=10.1007/s00134-008-1231-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Tuxen DV, Wilson JW, Cade JF. Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. <span><span class="ref-journal">Am Rev Respir Dis. </span>1987;<span class="ref-vol">136</span>(2):402\xe2\x80\x93405. doi: 10.1164/ajrccm/136.2.402.</span> [<a href="/pubmed/3039882" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm%2F136.2.402" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;title=Prevention+of+lower+respiratory+herpes+simplex+virus+infection+with+acyclovir+in+patients+with+the+adult+respiratory+distress+syndrome&amp;author=DV+Tuxen&amp;author=JW+Wilson&amp;author=JF+Cade&amp;volume=136&amp;issue=2&amp;publication_year=1987&amp;pages=402-405&amp;pmid=3039882&amp;doi=10.1164/ajrccm/136.2.402&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Camps K, Jorens PG, Demey HE, Pattyn SR, Ieven M. Clinical significance of herpes simplex virus in the lower respiratory tract of critically ill patients. <span><span class="ref-journal">Eur J Clin Microbiol Infect Dis. </span>2002;<span class="ref-vol">21</span>(10):758\xe2\x80\x93759. doi: 10.1007/s10096-002-0809-y.</span> [<a href="/pubmed/12415478" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs10096-002-0809-y" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Microbiol+Infect+Dis&amp;title=Clinical+significance+of+herpes+simplex+virus+in+the+lower+respiratory+tract+of+critically+ill+patients&amp;author=K+Camps&amp;author=PG+Jorens&amp;author=HE+Demey&amp;author=SR+Pattyn&amp;author=M+Ieven&amp;volume=21&amp;issue=10&amp;publication_year=2002&amp;pages=758-759&amp;pmid=12415478&amp;doi=10.1007/s10096-002-0809-y&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Luyt CE, Combes A, Deback C, Aubriot-Lorton MH, Nieszkowska A, Trouillet JL, Capron F, Agut H, Gibert C, Chastre J. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2007;<span class="ref-vol">175</span>(9):935\xe2\x80\x93942. doi: 10.1164/rccm.200609-1322OC.</span> [<a href="/pubmed/17234903" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200609-1322OC" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Herpes+simplex+virus+lung+infection+in+patients+undergoing+prolonged+mechanical+ventilation&amp;author=CE+Luyt&amp;author=A+Combes&amp;author=C+Deback&amp;author=MH+Aubriot-Lorton&amp;author=A+Nieszkowska&amp;volume=175&amp;issue=9&amp;publication_year=2007&amp;pages=935-942&amp;pmid=17234903&amp;doi=10.1164/rccm.200609-1322OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Liebau P, Kuse E, Winkler M, Schlitt HJ, Oldhafer K, Verhagen W, Flik J, Pichlmayr R. Management of herpes simplex virus type 1 pneumonia following liver transplantation. <span><span class="ref-journal">Infection. </span>1996;<span class="ref-vol">24</span>(2):130\xe2\x80\x93135. doi: 10.1007/BF01713317.</span> [<a href="/pubmed/8740105" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2FBF01713317" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection&amp;title=Management+of+herpes+simplex+virus+type+1+pneumonia+following+liver+transplantation&amp;author=P+Liebau&amp;author=E+Kuse&amp;author=M+Winkler&amp;author=HJ+Schlitt&amp;author=K+Oldhafer&amp;volume=24&amp;issue=2&amp;publication_year=1996&amp;pages=130-135&amp;pmid=8740105&amp;doi=10.1007/BF01713317&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Francois-Dufresne A, Garbino J, Ricou B, Wunderli W. ARDS caused by herpes simplex virus pneumonia in a patient with Crohn\'s disease: a case report. <span><span class="ref-journal">Intensive Care Med. </span>1997;<span class="ref-vol">23</span>(3):345\xe2\x80\x93347. doi: 10.1007/s001340050339.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7095420/">PMC free article</a>]</span> [<a href="/pubmed/9083240" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs001340050339" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med&amp;title=ARDS+caused+by+herpes+simplex+virus+pneumonia+in+a+patient+with+Crohn\'s+disease:+a+case+report&amp;author=A+Francois-Dufresne&amp;author=J+Garbino&amp;author=B+Ricou&amp;author=W+Wunderli&amp;volume=23&amp;issue=3&amp;publication_year=1997&amp;pages=345-347&amp;pmid=9083240&amp;doi=10.1007/s001340050339&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Kim EA, Lee KS, Primack SL, Yoon HK, Byun HS, Kim TS, Suh GY, Kwon OJ, Han J. Viral pneumonias in adults: radiologic and pathologic findings. <span><span class="ref-journal">Radiographics. </span>2002;<span class="ref-vol">22</span>(Spec No):S137\xe2\x80\x93149. doi: 10.1148/radiographics.22.suppl_1.g02oc15s137.</span> [<a href="/pubmed/12376607" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1148%2Fradiographics.22.suppl_1.g02oc15s137" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiographics&amp;title=Viral+pneumonias+in+adults:+radiologic+and+pathologic+findings&amp;author=EA+Kim&amp;author=KS+Lee&amp;author=SL+Primack&amp;author=HK+Yoon&amp;author=HS+Byun&amp;volume=22&amp;issue=Spec+No&amp;publication_year=2002&amp;pages=S137-149&amp;pmid=12376607&amp;doi=10.1148/radiographics.22.suppl_1.g02oc15s137&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Taplitz RA, Jordan MC. Pneumonia caused by herpesviruses in recipients of hematopoietic cell transplants. <span><span class="ref-journal">Semin Respir Infect. </span>2002;<span class="ref-vol">17</span>(2):121\xe2\x80\x93129. doi: 10.1053/srin.2002.33447.</span> [<a href="/pubmed/12070831" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1053%2Fsrin.2002.33447" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Respir+Infect&amp;title=Pneumonia+caused+by+herpesviruses+in+recipients+of+hematopoietic+cell+transplants&amp;author=RA+Taplitz&amp;author=MC+Jordan&amp;volume=17&amp;issue=2&amp;publication_year=2002&amp;pages=121-129&amp;pmid=12070831&amp;doi=10.1053/srin.2002.33447&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Ferrari A, Luppi M, Potenza L, Riva G, Morselli M, Imovilli A, Volzone F, Rossi G, Codeluppi M, Guaraldi G, et al.  Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. <span><span class="ref-journal">Leukemia. </span>2005;<span class="ref-vol">19</span>(11):2019\xe2\x80\x932021. doi: 10.1038/sj.leu.2403893.</span> [<a href="/pubmed/16049511" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fsj.leu.2403893" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Herpes+simplex+virus+pneumonia+during+standard+induction+chemotherapy+for+acute+leukemia:+case+report+and+review+of+literature&amp;author=A+Ferrari&amp;author=M+Luppi&amp;author=L+Potenza&amp;author=G+Riva&amp;author=M+Morselli&amp;volume=19&amp;issue=11&amp;publication_year=2005&amp;pages=2019-2021&amp;pmid=16049511&amp;doi=10.1038/sj.leu.2403893&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Cunha BA, Eisenstein LE, Dillard T, Krol V. Herpes simplex virus (HSV) pneumonia in a heart transplant: diagnosis and therapy. <span><span class="ref-journal">Heart Lung. </span>2007;<span class="ref-vol">36</span>(1):72\xe2\x80\x9378. doi: 10.1016/j.hrtlng.2006.07.005.</span> [<a href="/pubmed/17234480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.hrtlng.2006.07.005" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Heart+Lung&amp;title=Herpes+simplex+virus+(HSV)+pneumonia+in+a+heart+transplant:+diagnosis+and+therapy&amp;author=BA+Cunha&amp;author=LE+Eisenstein&amp;author=T+Dillard&amp;author=V+Krol&amp;volume=36&amp;issue=1&amp;publication_year=2007&amp;pages=72-78&amp;pmid=17234480&amp;doi=10.1016/j.hrtlng.2006.07.005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Gooskens J, Templeton KE, Claas EC, van Bussel MJ, Smit VT, Kroes AC. Quantitative detection of herpes simplex virus DNA in the lower respiratory tract. <span><span class="ref-journal">J Med Virol. </span>2007;<span class="ref-vol">79</span>(5):597\xe2\x80\x93604. doi: 10.1002/jmv.20861.</span> [<a href="/pubmed/17385683" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fjmv.20861" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Virol&amp;title=Quantitative+detection+of+herpes+simplex+virus+DNA+in+the+lower+respiratory+tract&amp;author=J+Gooskens&amp;author=KE+Templeton&amp;author=EC+Claas&amp;author=MJ+van+Bussel&amp;author=VT+Smit&amp;volume=79&amp;issue=5&amp;publication_year=2007&amp;pages=597-604&amp;pmid=17385683&amp;doi=10.1002/jmv.20861&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Reichenberger F, Dickenmann M, Binet I, Soler M, Bolliger C, Steiger J, Brunner F, Thiel G, Tamm M. Diagnostic yield of bronchoalveolar lavage following renal transplantation. <span><span class="ref-journal">Transpl Infect Dis. </span>2001;<span class="ref-vol">3</span>(1):2\xe2\x80\x937. doi: 10.1034/j.1399-3062.2001.003001002.x.</span> [<a href="/pubmed/11429033" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1034%2Fj.1399-3062.2001.003001002.x" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Transpl+Infect+Dis&amp;title=Diagnostic+yield+of+bronchoalveolar+lavage+following+renal+transplantation&amp;author=F+Reichenberger&amp;author=M+Dickenmann&amp;author=I+Binet&amp;author=M+Soler&amp;author=C+Bolliger&amp;volume=3&amp;issue=1&amp;publication_year=2001&amp;pages=2-7&amp;pmid=11429033&amp;doi=10.1034/j.1399-3062.2001.003001002.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Aisenberg G, Torres H, Tarrand J, Safdar A, Bodey G, Chemaly RF. Herpes simplex virus lower respiratory tract infection in patients with solid tumors. <span><span class="ref-journal">Cancer. </span>2009;<span class="ref-vol">115</span>(1):199\xe2\x80\x93206. doi: 10.1002/cncr.24011.</span> [<a href="/pubmed/19090003" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fcncr.24011" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Herpes+simplex+virus+lower+respiratory+tract+infection+in+patients+with+solid+tumors&amp;author=G+Aisenberg&amp;author=H+Torres&amp;author=J+Tarrand&amp;author=A+Safdar&amp;author=G+Bodey&amp;volume=115&amp;issue=1&amp;publication_year=2009&amp;pages=199-206&amp;pmid=19090003&amp;doi=10.1002/cncr.24011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Groeneveld AB, Vandenbroucke-Grauls CM. One swallow does not make a summer: can herpes simplex virus-1 cause pneumonia and acute lung injury? <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2007;<span class="ref-vol">175</span>(9):865\xe2\x80\x93866. doi: 10.1164/rccm.200701-133ED.</span> [<a href="/pubmed/17446341" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200701-133ED" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=One+swallow+does+not+make+a+summer:+can+herpes+simplex+virus-1+cause+pneumonia+and+acute+lung+injury?&amp;author=AB+Groeneveld&amp;author=CM+Vandenbroucke-Grauls&amp;volume=175&amp;issue=9&amp;publication_year=2007&amp;pages=865-866&amp;pmid=17446341&amp;doi=10.1164/rccm.200701-133ED&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. <span><span class="ref-journal">Curr Opin Rheumatol. </span>2003;<span class="ref-vol">15</span>(5):528\xe2\x80\x93534. doi: 10.1097/00002281-200309000-00002.</span> [<a href="/pubmed/12960476" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00002281-200309000-00002" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Rheumatol&amp;title=Infectious+complications+in+SLE+after+immunosuppressive+therapies&amp;author=I+Kang&amp;author=SH+Park&amp;volume=15&amp;issue=5&amp;publication_year=2003&amp;pages=528-534&amp;pmid=12960476&amp;doi=10.1097/00002281-200309000-00002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Doran MF, Crowson CS, Pond GR, O\'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. <span><span class="ref-journal">Arthritis Rheum. </span>2002;<span class="ref-vol">46</span>(9):2287\xe2\x80\x932293. doi: 10.1002/art.10524.</span> [<a href="/pubmed/12355475" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fart.10524" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Frequency+of+infection+in+patients+with+rheumatoid+arthritis+compared+with+controls:+a+population-based+study&amp;author=MF+Doran&amp;author=CS+Crowson&amp;author=GR+Pond&amp;author=WM+O\'Fallon&amp;author=SE+Gabriel&amp;volume=46&amp;issue=9&amp;publication_year=2002&amp;pages=2287-2293&amp;pmid=12355475&amp;doi=10.1002/art.10524&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Aquino SL, Dunagan DP, Chiles C, Haponik EF. Herpes simplex virus 1 pneumonia: patterns on CT scans and conventional chest radiographs. <span><span class="ref-journal">J Comput Assist Tomogr. </span>1998;<span class="ref-vol">22</span>(5):795\xe2\x80\x93800. doi: 10.1097/00004728-199809000-00024.</span> [<a href="/pubmed/9754119" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00004728-199809000-00024" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Comput+Assist+Tomogr&amp;title=Herpes+simplex+virus+1+pneumonia:+patterns+on+CT+scans+and+conventional+chest+radiographs&amp;author=SL+Aquino&amp;author=DP+Dunagan&amp;author=C+Chiles&amp;author=EF+Haponik&amp;volume=22&amp;issue=5&amp;publication_year=1998&amp;pages=795-800&amp;pmid=9754119&amp;doi=10.1097/00004728-199809000-00024&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Umans U, Golding RP, Duraku S, Manoliu RA. Herpes simplex virus 1 pneumonia: conventional chest radiograph pattern. <span><span class="ref-journal">Eur Radiol. </span>2001;<span class="ref-vol">11</span>(6):990\xe2\x80\x93994. doi: 10.1007/s003300000696.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7102036/">PMC free article</a>]</span> [<a href="/pubmed/11419176" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs003300000696" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Radiol&amp;title=Herpes+simplex+virus+1+pneumonia:+conventional+chest+radiograph+pattern&amp;author=U+Umans&amp;author=RP+Golding&amp;author=S+Duraku&amp;author=RA+Manoliu&amp;volume=11&amp;issue=6&amp;publication_year=2001&amp;pages=990-994&amp;pmid=11419176&amp;doi=10.1007/s003300000696&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Miller WT, Jr, Shah RM. Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations. <span><span class="ref-journal">AJR Am J Roentgenol. </span>2005;<span class="ref-vol">184</span>(2):613\xe2\x80\x93622. doi: 10.2214/ajr.184.2.01840613.</span> [<a href="/pubmed/15671387" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2214%2Fajr.184.2.01840613" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AJR+Am+J+Roentgenol&amp;title=Isolated+diffuse+ground-glass+opacity+in+thoracic+CT:+causes+and+clinical+presentations&amp;author=WT+Miller&amp;author=RM+Shah&amp;volume=184&amp;issue=2&amp;publication_year=2005&amp;pages=613-622&amp;pmid=15671387&amp;doi=10.2214/ajr.184.2.01840613&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Boivin G, Goyette N, Sergerie Y, Keays S, Booth T. Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis. <span><span class="ref-journal">J Clin Virol. </span>2006;<span class="ref-vol">37</span>(4):248\xe2\x80\x93251. doi: 10.1016/j.jcv.2006.09.006.</span> [<a href="/pubmed/17046320" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jcv.2006.09.006" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&amp;title=Longitudinal+evaluation+of+herpes+simplex+virus+DNA+load+during+episodes+of+herpes+labialis&amp;author=G+Boivin&amp;author=N+Goyette&amp;author=Y+Sergerie&amp;author=S+Keays&amp;author=T+Booth&amp;volume=37&amp;issue=4&amp;publication_year=2006&amp;pages=248-251&amp;pmid=17046320&amp;doi=10.1016/j.jcv.2006.09.006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Knight DA, Hejmanowski AQ, Dierksheide JE, Williams JW, Chong AS, Waldman WJ. Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. <span><span class="ref-journal">Transplantation. </span>2001;<span class="ref-vol">71</span>(1):170\xe2\x80\x93174. doi: 10.1097/00007890-200101150-00031.</span> [<a href="/pubmed/11211189" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1097%2F00007890-200101150-00031" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;title=Inhibition+of+herpes+simplex+virus+type+1+by+the+experimental+immunosuppressive+agent+leflunomide&amp;author=DA+Knight&amp;author=AQ+Hejmanowski&amp;author=JE+Dierksheide&amp;author=JW+Williams&amp;author=AS+Chong&amp;volume=71&amp;issue=1&amp;publication_year=2001&amp;pages=170-174&amp;pmid=11211189&amp;doi=10.1097/00007890-200101150-00031&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Afessa B. Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: a prospective, cohort study. <span><span class="ref-journal">BMC Pulm Med. </span>2001;<span class="ref-vol">1</span>:1. doi: 10.1186/1471-2466-1-1.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC57813/">PMC free article</a>]</span> [<a href="/pubmed/11602023" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1471-2466-1-1" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Pulm+Med&amp;title=Mycobacterial+and+nonbacterial+pulmonary+complications+in+hospitalized+patients+with+human+immunodeficiency+virus+infection:+a+prospective,+cohort+study&amp;author=B+Afessa&amp;volume=1&amp;publication_year=2001&amp;pages=1&amp;pmid=11602023&amp;doi=10.1186/1471-2466-1-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Simoons-Smit AM, Kraan EM, Beishuizen A, Strack van Schijndel RJ, Vandenbroucke-Grauls CM. Herpes simplex virus type 1 and respiratory disease in critically-ill patients: Real pathogen or innocent bystander? <span><span class="ref-journal">Clin Microbiol Infect. </span>2006;<span class="ref-vol">12</span>(11):1050\xe2\x80\x931059. doi: 10.1111/j.1469-0691.2006.01475.x.</span> [<a href="/pubmed/17002604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1469-0691.2006.01475.x" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Microbiol+Infect&amp;title=Herpes+simplex+virus+type+1+and+respiratory+disease+in+critically-ill+patients:+Real+pathogen+or+innocent+bystander?&amp;author=AM+Simoons-Smit&amp;author=EM+Kraan&amp;author=A+Beishuizen&amp;author=RJ+Strack+van+Schijndel&amp;author=CM+Vandenbroucke-Grauls&amp;volume=12&amp;issue=11&amp;publication_year=2006&amp;pages=1050-1059&amp;pmid=17002604&amp;doi=10.1111/j.1469-0691.2006.01475.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div><div class="ref-list-sec sec" id="BSec1"><h2 id="BSec1title">Pre-publication history</h2><ul class="back-ref-list" style="list-style-type:decimal;"><li id="CR29"><span class="mixed-citation">The pre-publication history for this paper can be accessed here:<a href="http://www.biomedcentral.com/1471-2466/9/22/prepub" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2705343&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.biomedcentral.com/1471-2466/9/22/prepub</a></span></li></ul></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2705343/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2705343/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2705343/pdf/12890_2008_Article_140.pdf">PDF (2.2M)</a></li> | <li><a href="#" data-citationid="PMC2705343" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2705343%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2705343%2F&amp;text=Occurrence%20of%20HSV-1-induced%20pneumonitis%20in%20patients%20under%20standard%20immunosuppressive%20therapy%20for%20rheumatic%2C%20vasculitic%2C%20and%20connective%20tissue%20disease"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2705343%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19450259" data-aiid="7091397" data-aid="2705343" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2705343" data-md5="f98b64a775e2abb6968130d0519f4c8a"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:18:56-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B6B75E9A37A5100000000055C055C&amp;ncbi_session=8A1B6B75E9A47701_1372SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2705343%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2705343/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B6B75E9A47701_1372SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'